These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7524380)

  • 1. [Use of high-dose aprotinin to stabilize hemostasis in artificial circulation].
    Dement'eva II; Piatnitskaia GKh; Dzemeshkevich SL; Charnaia MA
    Anesteziol Reanimatol; 1993; (1):66-70. PubMed ID: 7524380
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose aprotinin (trasylol) in reducing bleeding and protecting lung function in potential bleeders undergoing cardiopulmonary bypass.
    Liu B; Belboul A; al-Khaja N; Dernevik L; Raberts D; William-Olsson G
    Chin Med J (Engl); 1991 Dec; 104(12):980-5. PubMed ID: 1723673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low doses of aprotinin in reducing blood loss and allogenic transfusions in operation under conditions of extracorporeal circulation with using cell saver].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG
    Vestn Khir Im I I Grek; 2005; 164(6):69-73. PubMed ID: 16792320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass.
    Carrel T; Bauer E; Laske A; von Segesser L; Turina M
    Lancet; 1991 Mar; 337(8742):673. PubMed ID: 1705649
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of high doses of aprotinin to decrease blood loss in aortocoronary by-pass surgery.
    Dementieva II; Dzemeshkevich SL; Charnaya MA; Shabalkin BV
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):185-6. PubMed ID: 7539806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of high doses of aprotinin on intra- and postoperative blood loss in surgery with artificial circulation].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1995; (2):91-3. PubMed ID: 7544074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aprotinin in the correction of the hemodynamic syndrome of systemic inflammatory response in surgeries with extracorporeal circulation].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG; Kim SF
    Anesteziol Reanimatol; 2004; (4):15-9. PubMed ID: 15468547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The preventive role of large doses of aprotinin in decreasing the degree of metabolic disorders during aortocoronary bypass operations].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Ziuliaeva TP
    Anesteziol Reanimatol; 1996; (1):55-8. PubMed ID: 8686945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate.
    Shinfeld A; Zippel D; Lavee J; Lusky A; Shinar E; Savion N; Mohr R
    Ann Thorac Surg; 1995 Apr; 59(4):872-6. PubMed ID: 7535040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
    Charnaia MA; Morozov IuA; Gladysheva VG; Isaeva AM
    Anesteziol Reanimatol; 2006; (5):31-3. PubMed ID: 17184058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
    Royston D; Levy JH; Fitch J; Dietrich W; Body SC; Murkin JM; Spiess BD; Nadel A
    Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase inhibitors in thoracic surgery.
    Nordström S
    Acta Chir Scand Suppl; 1967; 378():71-5. PubMed ID: 4865431
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological properties of aprotinin and its therapeutic use in heart surgery].
    Carrera A; Fernández P; García del Valle S; de la Quintana B; Martínez MV
    Rev Esp Anestesiol Reanim; 1993; 40(5):292-9. PubMed ID: 7504313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aprotinin in open heart operations].
    Hack G; Kirchhoff PG; Popov-Cenić S; Kulzer R; Schlemminger B; Piepho A
    Med Welt; 1983 Jun; 34(25-26):726-31. PubMed ID: 6193394
    [No Abstract]   [Full Text] [Related]  

  • 18. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
    Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
    Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation.
    Mallett SV; Cox D; Burroughs AK; Rolles K
    Lancet; 1990 Oct; 336(8719):886-7. PubMed ID: 1699096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.